2014
DOI: 10.3109/21691401.2014.936063
|View full text |Cite
|
Sign up to set email alerts
|

Effect of oxygenated polyethylene glycol decorated hemoglobin on microvascular diameter and functional capillary density in the transgenic mouse model of sickle cell anemia

Abstract: Malemide polyethylene glycol-conjugated Hb (MP4OX, Sangart Inc.), a high-affinity low-concentration acellular hemoglobin (P50 = 5 mmHg, 4.3 g/dl) solution, has been shown to optimize microvascular perfusion and target oxygen delivery to anoxic tissue. Microvascular perfusion during an acute hypoxic challenge in a transgenic anemic sickle cell disease mouse model was studied with MP4OX and saline. Arterioles were dilated in both groups. Functional capillary density (FCD) was maintained at a higher level with MP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 32 publications
(33 reference statements)
0
2
0
Order By: Relevance
“…After unloading CO, the compound is oxygenated in the lung and thereby transforms into MP4OX. The effects of MP4OX have been further investigated in animal models of sickle cell anemia (Tsai et al, 2015). Relevant clinical trials with Hemospan/ MP4OX and MP4CO are listed in Supplemental Table 3.…”
Section: Classes Of Aocsmentioning
confidence: 99%
“…After unloading CO, the compound is oxygenated in the lung and thereby transforms into MP4OX. The effects of MP4OX have been further investigated in animal models of sickle cell anemia (Tsai et al, 2015). Relevant clinical trials with Hemospan/ MP4OX and MP4CO are listed in Supplemental Table 3.…”
Section: Classes Of Aocsmentioning
confidence: 99%
“…. As a consequence, clinical trials have been halted in 2011 [30] and none of the listed polyHbs have been approved for general use by the U.S. Food and Drug Administration (FDA) or European Medicines Agency [15,[31][32][33][34][35][36].…”
Section: Mammalian Hemoglobin-based Oxygen Carriersmentioning
confidence: 99%